0001415889-22-012505.txt : 20221213 0001415889-22-012505.hdr.sgml : 20221213 20221213172522 ACCESSION NUMBER: 0001415889-22-012505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221209 FILED AS OF DATE: 20221213 DATE AS OF CHANGE: 20221213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fernandes Peter CENTRAL INDEX KEY: 0001642618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 221460521 MAIL ADDRESS: STREET 1: PERRYVILLE III CORPORATE PARK STREET 2: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 form4-12132022_051211.xml X0306 4 2022-12-09 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001642618 Fernandes Peter 184 LIBERTY CORNER RD. SUITE 302 WARREN NJ 07059 false true false false PRINCIPAL EXECUTIVE OFFICER Common Stock 2022-12-09 4 M 0 32500 A 32500 D Common Stock 2022-12-09 4 F 0 9985 0.9301 D 22515 D Restricted Stock Units 2022-12-09 4 M 0 32500 0 D Common Stock 32500 32500 D Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. On January 26, 2022, the reporting person was granted 65,000 restricted stock units, 50% vesting on December 9, 2022 and 50% vesting on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date. /s/ Peter Fernandes 2022-12-13